Abstract

TPS4155Background: Trifluridine/tipiracil (FTD/TPI, also known as TAS-102) is a combination of a nucleoside analogue and a thymidine phosphorylase inhibitor. TAS-102 has shown activity in 5FU-resis...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
P-49 GOBLET: A phase 1/2 multiple indication signal finding and biomarker study in advanced gastrointestinal cancers treated with pelareorep and atezolizumab – safety and preliminary response results
M Collienne ... T Heineman
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 33
M Collienne, et. al.M Collienne ... T Heineman
01 Jun 2022
PD-4 A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers
O Alese ... B El-Rayes
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 32
O Alese, et. al.O Alese ... B El-Rayes
01 Jul 2021
Illness Understanding, Prognostic Awareness, and End-of-Life Care in Patients With GI Cancer and Malignant Bowel Obstruction With Drainage Percutaneous Endoscopic Gastrostomy.
Jessica I Goldberg ... Debra A Goldman
JCO Oncology Practice | VOL. 17
Jessica I Goldberg, et. al.Jessica I Goldberg ... Debra A Goldman
06 Aug 2020
Discovery of 5-Substituted-6-chlorouracils as Efficient Inhibitors of Human Thymidine Phosphorylase
Radim Nencka ... Milena Masojídková
Journal of Medicinal Chemistry | VOL. 50
Radim Nencka, et. al.Radim Nencka ... Milena Masojídková
27 Oct 2007
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Michael D Jain ... Saurabh Dahiya
Journal of Clinical Oncology | VOL. -
Michael D Jain, et. al.Michael D Jain ... Saurabh Dahiya
02 Aug 2024
Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms
Melissa A Richard ... Ravi Bhatia
Journal of Clinical Oncology | VOL. -
Melissa A Richard, et. al.Melissa A Richard ... Ravi Bhatia
02 Aug 2024
Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
Vinayak Venkataraman ... Suzanne George
Journal of Clinical Oncology | VOL. -
Vinayak Venkataraman, et. al.Vinayak Venkataraman ... Suzanne George
02 Aug 2024
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
Lori J Wirth ... Philippe A Cassier
Journal of Clinical Oncology | VOL. -
Lori J Wirth, et. al.Lori J Wirth ... Philippe A Cassier
02 Aug 2024
View more papers